A transcriptome signature of endothelial lymphatic cells coexists with the chronic oxidative stress signature in radiation-induced post-radiotherapy breast angiosarcomas

Carcinogenesis

Volumn 33, Issue 7, 2012, Pages 1399-1405

  Hadj Hamou, Nabila Sandra ^a,b,c   Laé, Marick ^a   Almeida, Anna ^a   Grange, Pierre de la ^d   Kirova, Youlia ^a   Sastre Garau, Xavier ^a   Malfoy, Bernard ^a,b,c  

^a INSTITUT CURIE   (France)

^b CNRS   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN A RECEPTOR; HOMEODOMAIN PROTEIN; MYC PROTEIN; PODOPLANIN; PROSPERO HOMEOBOX 1 PROTEIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3;

ANGIOSARCOMA; ARTICLE; BREAST ANGIOSARCOMA; CANCER RADIOTHERAPY; CARCINOGENESIS; CONTROLLED STUDY; COPY NUMBER VARIATION; ENDOTHELIAL LYMPHATIC CELL; ENDOTHELIUM CELL; EXON; GENE AMPLIFICATION; GENE EXPRESSION; HISTOPATHOLOGY; IRRADIATION; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIMARY TUMOR; PRIORITY JOURNAL;

BREAST NEOPLASMS; ENDOTHELIUM; FEMALE; GENE DOSAGE; HEMANGIOSARCOMA; HUMANS; LYMPH NODES; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84865183987     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgs155     Document Type: Article

References (50)

1. Suit,H. et al. (2007) Secondary carcinogenesis in patients treated with radiation: a review of data on radiation-induced cancers in human, non-human primate, canine and rodent subjects. Radiat. Res., 167, 12-42.
2. Hadj-Hamou,N.S. et al. (2011) A transcriptome signature distinguished sporadic from postradiotherapy radiation-induced sarcomas. Carcinogenesis, 32, 929-934.
3. Ory,C. et al. (2011) Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumors. Endocr. Relat. Cancer, 18, 193-206.
4. Ugolin,N. et al. (2011) Strategy to find molecular signatures in a small series of rare cancers: validation for radiation-induced breast and thyroid tumors. PLoS One, 6, e23581.
5. Adem,C. et al. (2004) Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature. Br. J. Cancer, 91, 237-241.
6. Kirova,Y.M. et al. (2005) Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review. Cancer, 104, 856-863.
7. Kirova,Y.M. et al. (2007) Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review. Int. J. Radiat. Oncol. Biol. Phys., 68, 359-363.
8. Sheppard,D.G. et al. (2001) Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases. Clin. Radiol., 56, 22-29.
9. Huang,J. et al. (2001) Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer, 92, 172-180.
10. Manner,J. et al. (2010) MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am. J. Pathol., 176, 34-39.
11. Guo,T. et al. (2010) Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions. Genes Chromosomes Cancer, 50, 25-33.
12. Mentzel,T. et al. (2012) Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases. Mod. Pathol., 25, 75-85.
13. Cahan,W.G. et al. (1948) Sarcoma arising in irradiated bone. Cancer, 1, 3-29.
14. de la Grange,P. et al. (2007) A new advance in alternative splicing databases: from catalogue to detailed analysis of regulation of expression and function of human alternative splicing variants. BMC Bioinformatics, 8, 180.
15. de la Grange,P. et al. (2005) FAST DB: a website resource for the study of the expression regulation of human gene products. Nucleic Acids Res., 33, 4276-4284.
16. de la Grange,P. et al. (2010) Splicing factor and exon profiling across human tissues. Nucleic Acids Res., 38, 2825-2838.
17. Gibaud,A. et al. (2010) Extrachromosomal amplification mechanisms in a glioma with amplified sequences from multiple chromosome loci. Hum. Mol. Genet., 19, 1276-1285.
18. Lae,M. et al. (2010) Assessing HER2 gene amplification as a potential target for therapy in invasive urothelial bladder cancer with a standardized methodology: results in 1005 patients. Ann. Oncol., 21, 815-819.
19. Guan,Y. et al. (2007) Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin. Cancer Res., 13, 5745-5755.
20. Haverty,P.M. et al. (2009) High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors. BMC Med. Genomics, 2, 21.
21. Witte,J.S. (2007) Multiple prostate cancer risk variants on 8q24. Nat. Genet., 39, 579-580.
22. Ahmadiyeh,N. et al. (2010) 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc. Natl Acad. Sci. USA, 107, 9742-9746.
23. Albihn,A. et al. (2010) MYC in oncogenesis and as a target for cancer therapies. Adv. Cancer Res., 107, 163-224.
24. Martin,J. et al. (2011) Hit proteins, mitochondria and cancer. Biochim. Biophys. Acta, 1807, 626-632.
25. Burgner,D. et al. (2009) A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet, 5, e1000319.
26. Ilnytskyy,Y. et al. (2011) Non-targeted radiation effects-an epigenetic connection. Mutat. Res., 714, 113-125.
27. Muradyan,A. et al. (2011) Acute high-dose X-radiation-induced genomic changes in A549 cells. Radiat. Res., 175, 700-707.
28. Schacht,V. et al. (2003) T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema. EMBO J., 22, 3546-3556.
29. Spinella,F. et al. (2009) Endothelin-1 stimulates lymphatic endothelial cells and lymphatic vessels to grow and invade. Cancer Res., 69, 2669-2676.
30. Hong,Y.K. et al. (2002) Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev. Dyn., 225, 351-357.
31. Bahram,F. et al. (2010) VEGF-mediated signal transduction in lymphatic endothelial cells. Pathophysiology, 17, 253-261.
32. Wang,P. et al. (2011) Gene expression profile of lymphatic endothelial cells. Cell Biol. Int., 35, 1177-1187.
33. Petrova,T.V. et al. (2002) Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J., 21, 4593-4599.
34. Hirakawa,S. et al. (2003) Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am. J. Pathol., 162, 575-586.
35. Amatschek,S. et al. (2007) Blood and lymphatic endothelial cell-specific differentiation programs are stringently controlled by the tissue environment. Blood, 109, 4777-4785.
36. Quattrocchi,C.C. et al. (2002) Reelin is a serine protease of the extracellular matrix. J. Biol. Chem., 277, 303-309.
37. Samama,B. et al. (2005) Reelin immunoreactivity in lymphatics and liver during development and adult life. Anat. Rec. A Discov. Mol. Cell. Evol. Biol., 285, 595-599.
38. Irjala,H. et al. (2003) Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Cancer Res., 63, 4671-4676.
39. Marttila-Ichihara,F. et al. (2008) Macrophage mannose receptor on lymphatics controls cell trafficking. Blood, 112, 64-72.
40. Rivat,C. et al. (2005) Implication of STAT3 signaling in human colonic cancer cells during intestinal trefoil factor 3 (TFF3)-and vascular endothelial growth factor-mediated cellular invasion and tumor growth. Cancer Res., 65, 195-202.
41. Kannan,N. et al. (2010) Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma. Neoplasia, 12, 1041-1053.
42. Jackowski,S. et al. (2007) Radiogenic lymphangiogenesis in the skin. Am. J. Pathol., 171, 338-348.
43. Wang,H.W. et al. (2004) Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat. Genet., 36, 687-693.
44. Cheung,L. et al. (2005) The lymphatic biology of Kaposi's sarcoma. Lymphat. Res. Biol., 3, 25-35.
45. Dunworth,W.P. et al. (2009) G protein-coupled receptors as potential drug targets for lymphangiogenesis and lymphatic vascular diseases. Arterioscler. Thromb. Vasc. Biol., 29, 650-656.
46. Sodhi,A. et al. (2000) The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion throughmitogen-activated protein kinase and p.38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res., 60, 4873-4880.
47. Kaminski,M. et al. (2007) Novel role for mitochondria: protein kinase Ctheta-dependent oxidative signaling organelles in activation-induced T-cell death. Mol. Cell. Biol., 27, 3625-3639.
48. Duteil,D. et al. (2010) The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles. Cell Metab., 12, 496-508.
49. Kramerova,I. et al. (2009) Mitochondrial abnormalities, energy deficit and oxidative stress are features of calpain 3 deficiency in skeletal muscle. Hum. Mol. Genet., 18, 3194-3205.
50. Seminotti,B. et al. (2011) Neurochemical evidence that lysine inhibits synaptic Na+, K+-ATPase activity and provokes oxidative damage in striatum of young rats in vivo. Neurochem. Res., 36, 205-214.